NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 10, Pages 1526
Publisher
MDPI AG
Online
2019-09-23
DOI
10.3390/jcm8101526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular Adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under Hypoxia
- (2019) Ángelo Torres et al. CANCER LETTERS
- The landscape of the mesenchymal signature in brain tumours
- (2019) Jinan Behnan et al. BRAIN
- CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling
- (2019) Angela Yan et al. JOURNAL OF NEUROSCIENCE
- Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
- (2019) Alessio D’Alessio et al. Cancers
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- The Adenosine A3 Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia
- (2018) René Rocha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenosinergic signaling as a target for natural killer cell immunotherapy
- (2018) Jiao Wang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
- (2018) Andrea M. Chambers et al. Frontiers in Immunology
- Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
- (2018) Jiao Wang et al. Journal for ImmunoTherapy of Cancer
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- shinyGEO: a web-based application for analyzing gene expression omnibus datasets
- (2016) Jasmine Dumas et al. BIOINFORMATICS
- The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
- (2015) et al. SCIENCE
- Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
- (2015) Anna Díez-Villanueva et al. Epigenetics & Chromatin
- Molecular and cellular heterogeneity: the hallmark of glioblastoma
- (2014) Diane J. Aum et al. Neurosurgical Focus
- Gliomas and the vascular fragility of the blood brain barrier
- (2014) Luiz Gustavo Dubois et al. Frontiers in Cellular Neuroscience
- Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy
- (2014) S Daniele et al. Cell Death & Disease
- Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours
- (2013) Justyna Kmiecik et al. JOURNAL OF NEURO-ONCOLOGY
- Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
- (2013) Justyna Kmiecik et al. JOURNAL OF NEUROIMMUNOLOGY
- Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas
- (2013) Shuo Xu et al. NEURO-ONCOLOGY
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- CD73 and adenosine generation in the creation of regulatory microenvironments
- (2012) F. S. Regateiro et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
- (2012) Liuqi Yang et al. EXPERIMENTAL CELL RESEARCH
- 5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells
- (2012) Claudia Quezada et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors
- (2011) M. Sabry et al. JOURNAL OF IMMUNOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology
- (2011) Isaac Yang et al. JOURNAL OF NEUROSURGERY
- Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion
- (2011) Angélica Regina Cappellari et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres
- (2010) Eli E. Bar et al. AMERICAN JOURNAL OF PATHOLOGY
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
- (2009) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
- (2008) Luci Bavaresco et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started